2017
Incidence of Occupational Asthma and Exposure to Toluene Diisocyanate in the United States Toluene Diisocyanate Production Industry
Collins JJ, Anteau S, Conner PR, Cassidy LD, Doney B, Wang ML, Kurth L, Carson M, Molenaar D, Redlich CA, Storey E. Incidence of Occupational Asthma and Exposure to Toluene Diisocyanate in the United States Toluene Diisocyanate Production Industry. Journal Of Occupational And Environmental Medicine 2017, 59: s22-s27. PMID: 29200135, PMCID: PMC5763544, DOI: 10.1097/jom.0000000000000890.Peer-Reviewed Original Research
2015
Longitudinal assessment of lung function decline in the occupational setting
Redlich CA, Tarlo SM. Longitudinal assessment of lung function decline in the occupational setting. Current Opinion In Allergy And Clinical Immunology 2015, 15: 145-149. PMID: 25961387, DOI: 10.1097/aci.0000000000000153.Peer-Reviewed Original ResearchMeSH KeywordsHumansLungLung DiseasesOccupational DiseasesOccupational ExposureSpirometryTime FactorsConceptsLongitudinal lung functionLung functionLongitudinal spirometryMedical surveillanceFlavorings-related lung diseaseHazardous work exposuresLung function declineOccupational respiratory diseasesRecent longitudinal studiesFunction declineEarly diseaseLung diseaseOccupational exposureRespiratory diseaseWork exposureSpirometryPreventive interventionsLongitudinal assessmentFurther evaluationOccupational settingsDiseaseLongitudinal studyCliniciansExposureRecent studies
2014
Inception cohort study of workers exposed to toluene diisocyanate at a polyurethane foam factory: Initial one‐year follow‐up
Gui W, Wisnewski AV, Neamtiu I, Gurzau E, Sparer JA, Stowe MH, Liu J, Slade MD, Rusu OA, Redlich CA. Inception cohort study of workers exposed to toluene diisocyanate at a polyurethane foam factory: Initial one‐year follow‐up. American Journal Of Industrial Medicine 2014, 57: 1207-1215. PMID: 25266741, PMCID: PMC4198484, DOI: 10.1002/ajim.22385.Peer-Reviewed Original ResearchMeSH KeywordsAdultAir Pollutants, OccupationalAirway ObstructionAsthma, OccupationalFemaleFollow-Up StudiesForced Expiratory VolumeHumansImmunoglobulin EImmunoglobulin GLost to Follow-UpMaleMiddle AgedOccupational ExposurePolyurethanesPrevalenceProspective StudiesTime FactorsToluene 2,4-DiisocyanateVital CapacityYoung AdultConceptsAsthma symptomsIsocyanate asthmaInception cohort studyHealth effectsCurrent asthma symptomsTDI levelsFirst yearFurther longitudinal evaluationAirflow obstructionCohort studyInception cohortOccupational asthmaTDI exposureRespiratory healthSkin exposureLongitudinal evaluationAsthmaOne-yearPersonal samplingSymptomsRiskExposureFindingsFEV1Spirometry
2007
Slow Curing of Aliphatic Polyisocyanate Paints in Automotive Refinishing: A Potential Source for Skin Exposure
Bello D, Sparer J, Redlich CA, Ibrahim K, Stowe MH, Liu Y. Slow Curing of Aliphatic Polyisocyanate Paints in Automotive Refinishing: A Potential Source for Skin Exposure. Journal Of Occupational And Environmental Hygiene 2007, 4: 406-411. PMID: 17474030, DOI: 10.1080/15459620701341199.Peer-Reviewed Original Research
1999
Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET)
Redlich C, Chung J, Cullen M, Blaner W, Van Bennekum A, Berglund L. Effect of long-term beta-carotene and vitamin A on serum cholesterol and triglyceride levels among participants in the Carotene and Retinol Efficacy Trial (CARET). Atherosclerosis 1999, 143: 427-434. PMID: 10217373, DOI: 10.1016/s0021-9150(98)00303-7.Peer-Reviewed Original ResearchConceptsSerum triglyceride levelsHigh-density lipoproteinActive treatment groupLDL cholesterol levelsTriglyceride levelsCancer chemoprevention trialsCholesterol levelsSmall nonsignificant increaseCARET participantsCardiovascular mortalityTreatment groupsNonsignificant increaseLow-density lipoprotein cholesterol levelsLung cancer chemoprevention trialsRetinol Efficacy TrialActive treatment armsLipoprotein cholesterol levelsLung cancer mortalityLong-term supplementationActive intervention groupTreatment-induced changesSerum lipidsChemoprevention trialsHDL cholesterolActive treatment